About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

QStat in Liver Transplant | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT04114253

QStat in Liver Transplant

This study will assess the clinical performance of the Quantra System with the QStat Cartridge in the liver transplant population.

Lead sponsor: HemoSonics LLC•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

HemoSonics LLC

The Quantra System is a fully integrated and automated in vitro diagnostic device which uses SEER Sonorheometry, an ultrasound-based technology, to characterize the viscoelastic propoerties of a whole blood sample during coagulation. The Quantra QStat Cartridge was developed to monitor hemostasis in the trauma and liver transplant populations which may experience a range of coagulopathies of various etiologies including fibrinolytic defects. This single-center, prospective, observational stuey will evaluate the performance of the Quantra System with the QStat Cartridge as compared to corresponding measures determined using the TEG 5000.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Subject is ≥ 18 years of age
•Subject is undergoing deceased donor liver transplant and is a candidate for a TEG test to be performed to access coagulopathy during surgery.
•Subject is willing to participate, and is willing to consent (either prospectively or by deferred consent)

Exclusion Criteria

•Subject is younger than 18 years of age
•Subject is known to have received antifibrinolytic therapy immediately prior to the start of liver transplantation surgery.
•Subject is unable to provide written informed consent (either prior to performing any study related procedures or by deferred consent)
•Subject is currently enrolled in a distinct study that might confound the results of the proposed study
•Subject is affected by a condition that, in the opinion of the clinical team, may pose additional risks

Related studies

RECRUITINGPhase 2

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

NCT07217899 · Blood Loss, Surgical, Blood Loss, Postoperative, and more

RECRUITINGPhase 1

Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury

NCT01731444 · Blood Loss, Surgical

Effectiveness of a Intraoperative Blood Recovery System in Cardiovascular Surgery in Brazil

NCT06601582 · Cardiovascular Surgery, Blood Loss, Surgical

RECRUITINGPhase 4

Role of TXA in Patients Undergoing Breast Free Flap Reconstruction

NCT06428682 · Breast Cancer, Blood Loss, Surgical

Dose-Dependent Effects of Intraoperative Tranexamic Acid on Surgical Bleeding and Transfusion Requirements in Multilevel Thoracolumbar Spinal Surgery

NCT07288697 · Spinal Disorders, Degenerative Spine Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 5, 2021Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment30

Start dateSep 2019

Last updatedJan 5, 2021

Condition

Blood Loss, Surgical

Locations shown

University of Minnesota

Minneapolis, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 5, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions